Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy.

Front Endocrinol (Lausanne) · 2025 · PMC12037364 · PMID 40303635

Europe PMC DOI

hedged sentences

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

showed a trendp = 0.083so close (0.05 < p ≤ 0.1)

Age at diagnosis showed a trend toward statistical significance, with an estimated hazard ratio (HR) of 1.50 (95% CI: 0.95–2.38, p = 0.083), indicating a possible increase in mortality risk with advancing age.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Tumor grading (HR: 4.03, 95% CI: 0.85–19.10, p = 0.079) did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.